Re-examination of the Electrocardiogram in Boys With Duchenne Muscular Dystrophy and Correlation With Its Dilated Cardiomyopathy

Department of Pediatrics, The Ohio State University, and the Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
The American journal of cardiology (Impact Factor: 3.43). 01/2009; 103(2):262-5. DOI: 10.1016/j.amjcard.2008.08.064
Source: PubMed

ABSTRACT Duchenne muscular dystrophy (DMD) results in dilated cardiomyopathy (DC). Characteristic electrocardiographic (ECG) changes include short PR interval, right ventricular hypertrophy (RVH), prolonged QTc interval, and prominent Q waves in leads I, aVL, V5, and V6 or in leads II, III, aVF, V5, and V6. We re-examined the prevalence and correlation of ECG changes with DC in DMD. Electrograms of 115 patients with DMD were evaluated. DC was defined as an echocardiographic ejection fraction<55%. PR interval and RVH were based on age-based normal values. Abnormal Q waves were >or=4 mm. Abnormal QTc interval was >or=450 ms. ST-segment depression was defined as >0.5 mm. Fisher's exact test evaluated significant differences between groups and logistic regression determined whether number of ECG changes predicted DC. Forty had DC. No significant differences existed between the number of ECG changes in DC and non-DC groups (p=0.279). Distribution of findings included short PR interval (43%), RVH (37%), prominent Q waves in leads V5 (34%) and V6 (33%), prominent Q waves in leads I, aVL, V5, and V6 (3, 1 with DC), prominent Q waves in leads II, III, aVF, V5, and V6 (9, 4 with DC), long QTc interval (0), ST depression (2, 1 with DC), and flat/biphasic ST segments (38, 15 with DC). In conclusion, ECG changes are similar in patients with DMD regardless of presence of DC. Previously reported characteristic ECG changes are seen in a minority of DMD cases. The most common findings are short PR interval and RVH. Prominent Q waves in leads II, III, aVF, V5, and V6 are more likely.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The dystrophinopathies Duchenne and Becker muscular dystrophies (DMD and BMD) represent the most common inherited disorders of muscle. Improvements in cardiac care, attention to respiratory function, and judicious use of spinal correction surgery have led to increased survival in the DMD population. Meanwhile, advances in molecular therapeutics have led to promising therapies that are in or are entering clinical trials. An understanding of the dystrophinopathies, and recent advances in their molecular diagnosis and treatment, is of benefit to practicing neurologists.
    Neurologic Clinics 08/2014; 32(3):671–688. DOI:10.1016/j.ncl.2014.05.002 · 1.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The medical care of patients with Duchenne muscular dystrophy (DMD) is an interdisciplinary and multifaceted task. The vast majority of those affected show a nearly constant course which is reflected in a corresponding stage-oriented treatment concept. Although there is still no causal therapy available for DMD, the course and in particular the quality of life of patients can be decisively improved by established medical practices. The orthopedic problems of DMD patients include contractures of the upper and lower extremities as well as sitting instability due to progressive scoliosis with pelvic imbalance. The orthopedic treatment incorporates conservative measures, such as physiotherapy, provision of orthotic devices and wheelchairs as well as surgery to resolve contractures of the lower extremities and surgical stabilization of the spine. Furthermore, in these patients orthopedic surgeons and trauma surgeons are confronted with the treatment and prophylaxis of fractures induced by osteoporosis. An early onset of glucocorticoid therapy markedly delays the loss of motor abilities. An important aspect in the care of DMD patients is the timely prophylaxis and treatment of respiratory insufficiency with regular sessions of breathing therapy, learning breathing and coughing techniques and the sufficiently early start of non-invasive mechanically assisted ventilation. Of similar relevance are also the early recognition and cardioprotective treatment of cardiomyopathy. The orthopedic surgeon accompanies the patient and family through all stages of the disease and must be appropriately informed on current management and treatment strategies even outside the limits of the personal field of specialization.
    Der Orthopäde 06/2014; 43(7). DOI:10.1007/s00132-013-2217-7 · 0.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mutations of αB-crystallin (CryαB), a small heat shock protein abundantly expressed in cardiac and skeletal muscles, are known to cause desmin-related myopathies. The CryαB R120G allele has been linked to a familial desminopathy, and in the transgenic mice, causes a sudden death at about 28 weeks of age. To investigate the mechanisms of the sudden cardiac arrest of the CryαB R120G transgenic mice, we prepared the protein samples from the left ventricular tissues of the two different age groups (10 verses 28 weeks), and examined Ca(2+) handling proteins. We found that the expression levels of SERCA2,phospholamban, ryanodine receptor 2, and calsequestrin 2 were significantly decreased in the 28-week old CryαB R120G transgenic mice. In addition, low heart rate variability (HRV) such as heart rate, total power and low frequency was observed,and continuous ECG monitoring uncovered cardiac arrhythmias such as ventricular tachycardia, atrioventricular block and atrial flutter in the 28-week old CryαB R120G transgenic mice. In contrast, we found that the expression levels of endoplasmic reticulum (ER) degradation enhancing, α-mannosidase-like protein (EDEM), inositol requirement 1 (IRE1) and x-box binding protein 1 (XBP1) were significantly increased in the 28-week old CryαBR120G transgenic mice, suggesting that the CryαBR120G transgenic mice exhibited an increased ER stress. Together, our data suggest that the CryαB R120G dominant variant induces ER stress and impairs Ca(2+) regulation leading to an aging related cardiac dysfunction, arrhythmias and decreased autonomous tone with shortened lifespan. This article is protected by copyright. All rights reserved.
    Clinical and Experimental Pharmacology and Physiology 05/2014; DOI:10.1111/1440-1681.12253 · 2.41 Impact Factor